Monogram Orthopaedics initiated with a Buy at Roth MKM

Roth MKM analyst Jason Wittes initiated coverage of Monogram Orthopaedics (MGRM) with a Buy rating and $4 price target The firm believes Monogram’s mBos robotics platform simplifies surgery with autonomous cutting. It sees the company excelling in bone preparation and personalization, challenging Stryker’s dominance in robotics.